10x Genomics, Inc. — Director's Dealing 2020

Sep 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-09-16

Reporting Person: ROBERTS BRYAN E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-16	Class A Common Stock	J	911981	$0.00	Disposed	375844	Indirect
2020-09-18	Class A Common Stock	J	338019	$0.00	Disposed	37825	Indirect
2020-09-18	Class A Common Stock	J	121804	$0.00	Acquired	121804	Direct

Footnotes

F1: On September 16, 2020, Venrock Associates VI, L.P. ("VA VI") and Venrock Partners VI, L.P. ("VP VI") distributed an aggregate of 1,250,000 shares of Class A Common Stock to their limited partners and general partners pursuant to a Trading and Distribution Plan adopted on September 11, 2020 (the "Plan"). Pursuant to the terms of the Plan, of the 1,250,000 shares distributed, 313,898 shares were distributed by VA VI to its general partner, Venrock Management VI, LLC ("VM VI") and 24,121 shares were distributed by VP VI to its general partner, Venrock Partners Management VI, LLC ("VPM VI"). Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI, VP VI, VM VI and VPM VI, except to the extent of his pecuniary interests therein.

F2: Consists of 35,085 shares of Class A Common Stock held by VA VI, 2,740 shares of Class A Common Stock held by VP VI, 313,898 shares of Class A Common Stock held by VM VI and 24,121 shares of Class A Common Stock held by VPM VI. Dr. Roberts disclaims beneficial ownership over all shares held by VA VI, VP VI, VM VI and VPM VI, except to the extent of his pecuniary interests therein.

F3: On September 18, 2020, VM VI and VPM VI distributed an aggregate of 338,019 shares of Class A Common Stock to their members and participants pursuant to the Plan.

F4: Consists of 35,085 shares of Class A Common Stock held by VA VI and 2,740 shares of Class A Common Stock held by VP VI. Dr. Roberts is a member of VM VI and VPM VI and disclaims beneficial ownership over all shares held by VA VI and VP VI, except to the extent of his pecuniary interests therein.

F5: On September 18, 2020, Dr. Roberts received an aggregate of 121,804 shares of Class A Common Stock as part of the distribution of shares of VM VI and VPM VI pursuant to the terms of the Plan.